11
|
|
|
Odorant binding protein 2B |
LCN14, OBPIIb |
|
12
|
|
|
Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
ARHGEF30, RHABDO1, UNC89 |
|
13
|
|
|
Obscurin like cytoskeletal adaptor 1 |
- |
|
14
|
|
|
Otoconin 90 |
PLA2L |
|
15
|
|
|
OCA2 melanosomal transmembrane protein |
BEY, BEY1, BEY2, BOCA, D15S12, EYCL, EYCL2, EYCL3, HCL3, P, PED, SHEP1, SLC13B1 |
Amblyopia, Angelman syndrome, Asthma, Attention deficit hyperactivity disorder, Basal cell carcinoma, Eye neoplasms, Biliary tract cancer, Breast cancer, Brown oculocutaneous albinism, Cancer, Cataract, Cervical cancer, Colorectal cancer, Congenital nystagmus, Melanoma, Cutaneous squamous cell carcinoma, Endometrial cancer, Esophageal cancer, Estrogen-receptor negative breast cancer, Febrile convulsion, Gastric cancer, Hepatocellular carcinoma, Lung cancer, Non-hodgkins lymphoma, Non-melanoma skin carcinoma, Non-small cell lung carcinoma, Oculocutaneous albinism, Ovarian cancer, Ovarian serous carcinoma, Pancreatic cancer, Parkinson disease, Prader-willi syndrome, Prostate cancer, Respiratory system infectious disease, Seborrheic keratosis, Skin cancer, Skin neoplasms, Skin hair eye pigmentation variation, Squamous cell carcinoma, Diabetes mellitus type 2, Uveal melanomaView all (26 more) |
16
|
|
|
Occludin/ELL domain containing 1 |
FWP009, S863-9 |
|
17
|
|
|
OCIA domain containing 1 |
ASRIJ, OCIA, TPA018 |
|
18
|
|
|
OCIA domain containing 2 |
- |
|
19
|
|
|
Occludin |
BLCPMG, PPP1R115, PTORCH1 |
Rhinitis, Brain injuries, Breast neoplasms, Congenital microcephaly, Crohn disease, Hypertension, Global developmental delay, Hepatic veno occlusive disease, Kidney failure, Pseudo-torch syndrome, Splenomegaly |
20
|
|
|
OCRL inositol polyphosphate-5-phosphatase |
DENT2, Dent-2, INPP5F, LOCR, NPHL2, OCRL-1, OCRL1 |
|